Agios Pharmaceuticals | Lucro Bruto Sobre Vendas

Preço das Ações
26.53
Mudança Diária
-0.04 -0.15%
Mensal
-7.04%
Anual
-20.71%
Q1 Previsão
25.72




Lucro Bruto Sobre Vendas Alterar Data
AbbVie USD 10.47B 605M 2025-09
Agios Pharmaceuticals USD 11.2M 448K 2025-09
Alnylam Pharmaceuticals USD 1.05B 418.14M 2025-09
Amgen USD 6.48B 307M 2025-09
Arrowhead Research USD 256.47M 228.7M 2025-09
Astellas Pharma JPY 456.81B 38.02B 2025-12
AstraZeneca USD 12.39B 406M 2025-09
Bayer EUR 5.35B 1.02B 2025-09
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 631.2M 39.27M 2025-09
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Daiichi Sankyo JPY 439.83B 95.05B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Exelixis USD 579.18M 30.39M 2025-09
Gilead Sciences USD 5.58B 453M 2025-06
GlaxoSmithKline GBP 6.18B 106M 2025-12
Incyte USD 1.27B 130.22M 2025-09
Ionis Pharmaceuticals USD 155M 293M 2025-09
Merck USD 13.42B 431M 2025-09
Moderna USD 809M 791M 2025-09
Novartis USD 10.82B 695M 2025-09
Novartis USD 10.82B 694M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sarepta Therapeutics USD 247.9M 209.96M 2025-09
Vertex Pharmaceuticals USD 2.66B 104.4M 2025-09


Agios Pharmaceuticals Lucro Bruto Sobre Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.